Showing results (411-420 of 668) with videos related to
Sort By:
Pageof 67
Diabetology International|July 3, 2023
Correction to: Role of insulin action in the pathogenesis of diabetic complicationsKyoichiro TsuchiyaDiabetology International|July 3, 2023
Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55Sanae Teshigawara, Atsuhito Tone, Akihiro Katayama, et al.Diabetology International|July 3, 2023
Diabetic lipemia as a predisposing state to acute pancreatitis: a case report and literature reviewYuka Hirakuni, Tomoyo Itonaga, Fumika Matsuda, et al.Diabetology International|January 4, 2019
Correction to: IAPP/amylin and β‑cell failure: implication of the risk factors of type 2 diabetesAzuma Kanatsuka, Shigetake Kou, Hideichi MakinoDiabetology International|January 4, 2019
Implications of using HBA1C as a diagnostic marker for diabetesNadia HussainDiabetology International|January 4, 2019
Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomized crossover pharmaceutical mechanistic studyYoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, et al.Diabetology International|January 4, 2019
Glucose area under the curve during oral glucose tolerance test as an index of glucose intoleranceKazuhiko Sakaguchi, Kazuo Takeda, Mitsuo Maeda, et al.Diabetology International|January 4, 2019
A case of glucocorticoid-induced diabetes in which the efficacy between sitagliptin and metformin was comparedChisaki Ishibashi, Tetsuyuki Yasuda, Taka-Aki Matsuoka, et al.Diabetology International|January 4, 2019
Effect of cinnamon supplementation on glucose, lipids levels, glomerular filtration rate, and blood pressure of subjects with type 2 diabetes mellitusChintana Sengsuk, Sawitra Sanguanwong, Orathai Tangvarasittichai, et al.Diabetology International|January 4, 2019
Complementary glucagonostatic and insulinotropic effects of DPP-4 inhibitors in the glucose-lowering action in Japanese patients with type 2 diabetesKen-Ichi Hashimoto, Yukio Horikawa, Jun TakedaPageof 67